Inpharma Weekly

, Volume 1562, Issue 1, pp 16–16 | Cite as

Erlotinib effective against GEJ, but not gastric, cancers

Clinical study
  • 4 Downloads

Keywords

Gastric Cancer Adenocarcinoma Partial Response Erlotinib Objective Response 

Copyright information

© Adis International Ltd 2006

Personalised recommendations